Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 249 articles:
HTML format



Single Articles


    July 2022
  1. CHOI SJ, Choi SH, Lee DY, Lee JS, et al
    Diagnostic value of [(68) Ga]Ga-DOTA-labeled-somatostatin analogue PET/MRI for detecting liver metastasis in patients with neuroendocrine tumors: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:4628-4637.
    PubMed     Abstract available


    June 2022
  2. DIMOV IP, Tous C, Li N, Barat M, et al
    Assessment of hepatic arterial hemodynamics with 4D flow MRI: in vitro analysis of motion and spatial resolution related error and in vivo feasibility study in 20 volunteers.
    Eur Radiol. 2022 Jun 22. pii: 10.1007/s00330-022-08890.
    PubMed     Abstract available


  3. KENNEDY P, Stocker D, Carbonell G, Said D, et al
    MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
    Eur Radiol. 2022 Jun 21. pii: 10.1007/s00330-022-08935.
    PubMed     Abstract available


  4. HWANG JA, Jeong WK, Kang HJ, Lee ES, et al
    Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08900.
    PubMed     Abstract available


  5. JIAO CY, Zhang H, Ji GW, Xu Q, et al
    CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
    Eur Radiol. 2022 Jun 16. pii: 10.1007/s00330-022-08914.
    PubMed     Abstract available


  6. PENG Y, Shen H, Tang H, Huang Y, et al
    Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 9. pii: 10.1007/s00330-022-08917.
    PubMed     Abstract available


  7. DE COBELLI F, Calandri M, Della Corte A, Sirovich R, et al
    Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    Eur Radiol. 2022;32:4147-4159.
    PubMed     Abstract available


  8. ZHANG K, Xie SS, Li WC, Ye ZX, et al
    Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators.
    Eur Radiol. 2022;32:4186-4197.
    PubMed     Abstract available


    May 2022
  9. HUANG Z, Zhou P, Li S, Li K, et al
    Evaluation of contrast-enhanced ultrasound LI-RADS version 2017: application on 271 liver nodules in individuals with non-alcoholic steatohepatitis.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08872.
    PubMed     Abstract available


  10. MENG D, Liang C, Zheng Y, Wang X, et al
    The value of gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients.
    Eur Radiol. 2022 May 31. pii: 10.1007/s00330-022-08874.
    PubMed     Abstract available


  11. TAGO K, Tsukada J, Sudo N, Shibutani K, et al
    Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma.
    Eur Radiol. 2022 May 20. pii: 10.1007/s00330-022-08852.
    PubMed     Abstract available


  12. PAN J, Li W, Gu L, Liu C, et al
    Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma: a meta-analysis.
    Eur Radiol. 2022 May 17. pii: 10.1007/s00330-022-08826.
    PubMed     Abstract available


  13. WEI H, Jiang H, Qin Y, Wu Y, et al
    Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study.
    Eur Radiol. 2022 May 13. pii: 10.1007/s00330-022-08811.
    PubMed     Abstract available


  14. HEO S, Kim DW, Choi SH, Kim SW, et al
    Diagnostic performance of liver fibrosis assessment by quantification of liver surface nodularity on computed tomography and magnetic resonance imaging: systematic review and meta-analysis.
    Eur Radiol. 2022;32:3377-3387.
    PubMed     Abstract available


  15. SHIN J, Lee S, Hwang JA, Lee JE, et al
    MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:3319-3326.
    PubMed     Abstract available


  16. TANG A, Dzyubak B, Yin M, Schlein A, et al
    MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Eur Radiol. 2022;32:2937-2948.
    PubMed     Abstract available


  17. PARK S, Yoon JH, Joo I, Yu MH, et al
    Image quality in liver CT: low-dose deep learning vs standard-dose model-based iterative reconstructions.
    Eur Radiol. 2022;32:2865-2874.
    PubMed     Abstract available


  18. GHADIMI M, Birnbaum J, Kamel IR, Sirlin CB, et al
    What proportion of LI-RADS 5 observations reported in clinical practice do not meet LI-RADS 5 criteria?
    Eur Radiol. 2022;32:3327-3333.
    PubMed     Abstract available


    April 2022
  19. QIU Z, Wang G, Yan H, Qi H, et al
    TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
    Eur Radiol. 2022 Apr 20. pii: 10.1007/s00330-022-08705.
    PubMed     Abstract available


  20. ZHANG W, Wang J, Linghu R, Chen X, et al
    Correction to: Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Apr 12. pii: 10.1007/s00330-022-08727.
    PubMed    


  21. MULLER L, Kloeckner R, Mahringer-Kunz A, Stoehr F, et al
    Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08737.
    PubMed     Abstract available


  22. WANG X, Tan Y, Liu D, Shen H, et al
    Chemotherapy-associated steatohepatitis was concomitant with epicardial adipose tissue volume increasing in breast cancer patients who received neoadjuvant chemotherapy.
    Eur Radiol. 2022 Apr 8. pii: 10.1007/s00330-022-08581.
    PubMed     Abstract available


  23. XIA D, Wang Q, Bai W, Wang E, et al
    Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
    Eur Radiol. 2022 Apr 6. pii: 10.1007/s00330-022-08716.
    PubMed     Abstract available


  24. LEE T, Lee JM, Yoon JH, Joo I, et al
    Deep learning-based image reconstruction of 40-keV virtual monoenergetic images of dual-energy CT for the assessment of hypoenhancing hepatic metastasis.
    Eur Radiol. 2022 Apr 5. pii: 10.1007/s00330-022-08728.
    PubMed     Abstract available


  25. ZHANG YN, Fowler KJ, Boehringer AS, Montes V, et al
    Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Eur Radiol. 2022;32:2457-2469.
    PubMed     Abstract available


  26. DOEMEL LA, Santana JG, Savic LJ, Gaupp FML, et al
    Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
    Eur Radiol. 2022;32:2437-2447.
    PubMed     Abstract available


  27. BENOIT C, Rodrigues A, Calderaro J, Charpy C, et al
    Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.
    Eur Radiol. 2022;32:2481-2491.
    PubMed     Abstract available


    March 2022
  28. YOUN SY, Kim B, Kim DH, Choi HJ, et al
    Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Eur Radiol. 2022 Mar 29. pii: 10.1007/s00330-022-08720.
    PubMed     Abstract available


  29. WANG Y, Zhu GQ, Zhou CW, Li N, et al
    Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors.
    Eur Radiol. 2022 Mar 22. pii: 10.1007/s00330-022-08691.
    PubMed     Abstract available


  30. SHENG R, Huang X, Jin K, Gao S, et al
    Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Mar 17. pii: 10.1007/s00330-022-08679.
    PubMed     Abstract available


  31. LUO N, Huang X, Ji Y, Jin G, et al
    A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection.
    Eur Radiol. 2022 Mar 16. pii: 10.1007/s00330-022-08656.
    PubMed     Abstract available


  32. PAN J, Tao Y, Chi X, Yang L, et al
    Do transition and hepatobiliary phase hypointensity improve LI-RADS categorization as an alternative washout: a systematic review and meta-analysis.
    Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08665.
    PubMed     Abstract available


  33. YOON JK, Choi JY, Rhee H, Park YN, et al
    MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
    Eur Radiol. 2022 Mar 8. pii: 10.1007/s00330-022-08643.
    PubMed     Abstract available


  34. KONG J, Gao R, Wu S, Shi Y, et al
    Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08634.
    PubMed    


  35. COSTANTINO A, Piagnani A, Nandi N, Sciola V, et al
    Reproducibility and diagnostic accuracy of pocket-sized ultrasound devices in ruling out compensated cirrhosis of mixed etiology.
    Eur Radiol. 2022 Mar 3. pii: 10.1007/s00330-022-08572.
    PubMed     Abstract available


  36. YAN Y, Xing X, Wang X, Yang L, et al
    Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Eur Radiol. 2022;32:2078-2088.
    PubMed     Abstract available


  37. BOS D, Yu S, Luong J, Chu P, et al
    Diagnostic reference levels and median doses for common clinical indications of CT: findings from an international registry.
    Eur Radiol. 2022;32:1971-1982.
    PubMed     Abstract available


  38. WANG Q, Wang A, Sparrelid E, Zhang J, et al
    Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review.
    Eur Radiol. 2022;32:1792-1803.
    PubMed     Abstract available


  39. CANNELLA R, Vernuccio F, Antonucci M, Gagliano DS, et al
    LI-RADS ancillary features favoring benignity: is there a role in LR-5 observations?
    Eur Radiol. 2022;32:1804-1812.
    PubMed     Abstract available


  40. DIOGUARDI BURGIO M, Sartoris R, Beaufrere A, Gregory J, et al
    Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.
    Eur Radiol. 2022;32:1781-1791.
    PubMed     Abstract available


  41. SCHATTENBERG JM, Emrich T
    Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
    Eur Radiol. 2022;32:1757-1759.
    PubMed    


  42. LUDEMANN W, Kahn J, Pustelnik D, Hardt J, et al
    Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
    Eur Radiol. 2022 Mar 1. pii: 10.1007/s00330-022-08585.
    PubMed     Abstract available


    February 2022
  43. ZHANG W, Wang J, Linghu R, Chen X, et al
    Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08569.
    PubMed     Abstract available


  44. PARK HJ, Lee TY, Kim SY, Kim MJ, et al
    Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Eur Radiol. 2022 Feb 28. pii: 10.1007/s00330-022-08623.
    PubMed     Abstract available


  45. LIU Y, Tan HY, Zhang XG, Zhen YH, et al
    Prediction of high-risk esophageal varices in patients with chronic liver disease with point and 2D shear wave elastography: a systematic review and meta-analysis.
    Eur Radiol. 2022 Feb 15. pii: 10.1007/s00330-022-08601.
    PubMed     Abstract available


  46. LI M, Yin Z, Hu B, Guo N, et al
    MR Elastography-Based Shear Strain Mapping for Assessment of Microvascular Invasion in Hepatocellular Carcinoma.
    Eur Radiol. 2022 Feb 11. pii: 10.1007/s00330-022-08578.
    PubMed     Abstract available


  47. SERBANESCU-KELE APOR DE ZALAN , Ruiter SJS, van den Berg AP, Pennings JP, et al
    Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation.
    Eur Radiol. 2022 Feb 8. pii: 10.1007/s00330-021-08515.
    PubMed     Abstract available


  48. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2022 Feb 7. pii: 10.1007/s00330-022-08548.
    PubMed     Abstract available


  49. XIONG J, Luo J, Bian J, Wu J, et al
    Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Eur Radiol. 2022;32:1285-1296.
    PubMed     Abstract available


  50. LI X, Qi Z, Du H, Geng Z, et al
    Deep convolutional neural network for preoperative prediction of microvascular invasion and clinical outcomes in patients with HCCs.
    Eur Radiol. 2022;32:771-782.
    PubMed     Abstract available


  51. MIN JH, Kim JM, Kim YK, Kim H, et al
    A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
    Eur Radiol. 2022;32:912-922.
    PubMed     Abstract available


  52. SUN C, Zhang X, Chen X, Zhu T, et al
    Single-direction diffusion-weighted imaging may be a simple complementary sequence for evaluating fetal corpus callosum.
    Eur Radiol. 2022;32:1135-1143.
    PubMed     Abstract available


    January 2022
  53. ZHENG H, Liu K, Yang Y, Liu B, et al
    Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-022-08537.
    PubMed     Abstract available


  54. KONG J, Gao R, Wu S, Shi Y, et al
    Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.
    Eur Radiol. 2022 Jan 29. pii: 10.1007/s00330-021-08425.
    PubMed     Abstract available


  55. KELAHAN LC, Kim D, Soliman M, Avery RJ, et al
    Role of hepatic metastatic lesion size on inter-reader reproducibility of CT-based radiomics features.
    Eur Radiol. 2022 Jan 26. pii: 10.1007/s00330-021-08526.
    PubMed     Abstract available


  56. DONG SY, Wang WT, Chen XS, Yang YT, et al
    Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI.
    Eur Radiol. 2022 Jan 25. pii: 10.1007/s00330-021-08495.
    PubMed     Abstract available


  57. YOUNG S, Chen T, Flanagan S, Golzarian J, et al
    Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation.
    Eur Radiol. 2022 Jan 15. pii: 10.1007/s00330-021-08501.
    PubMed     Abstract available


  58. SUN SH, Eche T, Dorczynski C, Otal P, et al
    Predicting death or recurrence of portal hypertension symptoms after TIPS procedures.
    Eur Radiol. 2022 Jan 11. pii: 10.1007/s00330-021-08437.
    PubMed     Abstract available


  59. LIU C, Shen Z, Ma H, Wang X, et al
    Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure.
    Eur Radiol. 2022 Jan 6. pii: 10.1007/s00330-021-08440.
    PubMed     Abstract available


  60. WACKENTHALER A, Moliere S, Artzner T, Michard B, et al
    Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure.
    Eur Radiol. 2022;32:12-21.
    PubMed     Abstract available


  61. JEON SK, Joo I, Bae JS, Park SJ, et al
    LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2022;32:46-55.
    PubMed     Abstract available


    December 2021
  62. AUER TA, Fehrenbach U, Grieser C, Penzkofer T, et al
    Correction to: Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Eur Radiol. 2021 Dec 5. pii: 10.1007/s00330-021-08386.
    PubMed    


  63. GHANI MA, Fereydooni A, Chen E, Letzen B, et al
    Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Eur Radiol. 2021;31:8858-8867.
    PubMed     Abstract available


  64. LI M, Yang H, Liu Y, Zhang L, et al
    Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis.
    Eur Radiol. 2021;31:9468-9478.
    PubMed     Abstract available


  65. YIN Y, Yakar D, Dierckx RAJO, Mouridsen KB, et al
    Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model.
    Eur Radiol. 2021;31:9620-9627.
    PubMed     Abstract available


  66. SCHEGERER AA, Frija G, Paulo G, Jaschke W, et al
    Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID.
    Eur Radiol. 2021;31:9346-9360.
    PubMed     Abstract available


    November 2021
  67. GRIESER C
    Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:8374-8375.
    PubMed    


  68. MARKICH R, Palussiere J, Catena V, Cazayus M, et al
    Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Eur Radiol. 2021;31:8302-8314.
    PubMed     Abstract available


  69. QU Y, Middleton MS, Loomba R, Glaser KJ, et al
    Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Eur Radiol. 2021;31:8408-8419.
    PubMed     Abstract available


  70. FAN W, Guo J, Zhu B, Wang S, et al
    Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS.
    Eur Radiol. 2021;31:8291-8301.
    PubMed     Abstract available


  71. HAM JH, Yu JS, Choi JM, Cho ES, et al
    Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (
    Eur Radiol. 2021;31:8628-8637.
    PubMed     Abstract available


  72. LU X, Zhou H, Wang K, Jin J, et al
    Comparing radiomics models with different inputs for accurate diagnosis of significant fibrosis in chronic liver disease.
    Eur Radiol. 2021;31:8743-8754.
    PubMed     Abstract available


    October 2021
  73. YANG J, Huang JY, Chen X, Ling WW, et al
    Correction to: Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Oct 14. pii: 10.1007/s00330-021-08256.
    PubMed    


  74. BARGELLINI I, Lorenzoni V, Lorenzoni G, Scalise P, et al
    Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naive patients: a propensity score matching analysis.
    Eur Radiol. 2021;31:7512-7522.
    PubMed     Abstract available


  75. KONG C, Zhao Z, Chen W, Lv X, et al
    Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Eur Radiol. 2021;31:7500-7511.
    PubMed     Abstract available


  76. RONG D, Liu W, Kuang S, Xie S, et al
    Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Eur Radiol. 2021;31:7584-7593.
    PubMed     Abstract available


  77. GUPTA P, Bansal A, Das GC, Kumar-M P, et al
    Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:7725-7733.
    PubMed     Abstract available


    September 2021
  78. CARBONELL G, Kennedy P, Bane O, Kirmani A, et al
    Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 26. pii: 10.1007/s00330-021-08282.
    PubMed     Abstract available


  79. JANG JK, Kim SY, Yoo IW, Cho YB, et al
    Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Eur Radiol. 2021 Sep 21. pii: 10.1007/s00330-021-08269.
    PubMed     Abstract available


  80. YU Y, Fan Y, Wang X, Zhu M, et al
    Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
    Eur Radiol. 2021 Sep 4. pii: 10.1007/s00330-021-08250.
    PubMed     Abstract available


  81. FRONDA M, Doriguzzi Breatta A, Gatti M, Calandri M, et al
    Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE.
    Eur Radiol. 2021;31:6578-6588.
    PubMed     Abstract available


  82. KANG JH, Choi SH, Lee JS, Kim KW, et al
    Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6856-6867.
    PubMed     Abstract available


  83. LI W, Li L, Zhuang BW, Ruan SM, et al
    Inter-reader agreement of CEUS LI-RADS among radiologists with different levels of experience.
    Eur Radiol. 2021;31:6758-6767.
    PubMed     Abstract available


  84. WANG G, Xie X, Chen H, Zhong Z, et al
    Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study.
    Eur Radiol. 2021;31:6747-6757.
    PubMed     Abstract available


  85. GUPTA P, Maralakunte M, Sagar S, Kumar-M P, et al
    Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:6511-6521.
    PubMed     Abstract available


  86. CANNELLA R, Fraum TJ, Ludwig DR, Borhani AA, et al
    Targetoid appearance on T2-weighted imaging and signs of tumor vascular involvement: diagnostic value for differentiating HCC from other primary liver carcinomas.
    Eur Radiol. 2021;31:6868-6878.
    PubMed     Abstract available


  87. LAIMER G, Jaschke N, Schullian P, Putzer D, et al
    Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
    Eur Radiol. 2021;31:6489-6499.
    PubMed     Abstract available


    August 2021
  88. OCAL O, Peynircioglu B, Loewe C, van Delden O, et al
    Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial.
    Eur Radiol. 2021 Aug 31. pii: 10.1007/s00330-021-08218.
    PubMed     Abstract available


  89. CHEN J, Allen AM, Therneau TM, Chen J, et al
    Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
    Eur Radiol. 2021 Aug 25. pii: 10.1007/s00330-021-08225.
    PubMed     Abstract available


  90. KIM GH, Kim PH, Kim JH, Kim PN, et al
    Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Eur Radiol. 2021 Aug 4. pii: 10.1007/s00330-021-08216.
    PubMed     Abstract available


  91. NAGAYAMA Y, Kato Y, Inoue T, Nakaura T, et al
    Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Eur Radiol. 2021;31:5779-5790.
    PubMed     Abstract available


  92. YOH T, Perrot A, Beaufrere A, Hobeika C, et al
    Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Eur Radiol. 2021;31:5830-5839.
    PubMed     Abstract available


  93. KOH DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, et al
    Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.
    Eur Radiol. 2021;31:5615-5628.
    PubMed     Abstract available


  94. CHENG MQ, Hu HT, Huang H, Pan JM, et al
    Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
    Eur Radiol. 2021;31:5680-5688.
    PubMed     Abstract available


  95. ALI A, Ahle M, Bjornsson B, Sandstrom P, et al
    Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:5464-5478.
    PubMed     Abstract available


  96. LEE DH, Lee ES, Bae JS, Lee JY, et al
    2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection.
    Eur Radiol. 2021;31:5802-5811.
    PubMed     Abstract available


  97. HABIBZADEH F, Habibzadeh P, Shakibafard A, Saidi F, et al
    Predicting the outcome of asymptomatic univesicular liver hydatids: diagnostic accuracy of unenhanced CT.
    Eur Radiol. 2021;31:5812-5817.
    PubMed     Abstract available


  98. LIU LH, Zhou GF, Lv H, Wang ZC, et al
    Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
    Eur Radiol. 2021;31:5640-5649.
    PubMed     Abstract available


    July 2021
  99. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    PubMed     Abstract available


  100. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    PubMed     Abstract available


  101. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    PubMed     Abstract available


  102. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    PubMed     Abstract available


  103. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    PubMed     Abstract available


  104. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    PubMed     Abstract available


  105. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    PubMed     Abstract available


  106. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    PubMed     Abstract available


    June 2021
  107. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    PubMed     Abstract available


  108. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    PubMed     Abstract available


  109. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    PubMed     Abstract available


  110. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    PubMed     Abstract available


  111. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    PubMed     Abstract available


  112. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    PubMed     Abstract available


    May 2021
  113. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    PubMed     Abstract available


  114. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    PubMed     Abstract available


  115. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    PubMed     Abstract available


  116. NOWAK S, Mesropyan N, Faron A, Block W, et al
    Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning.
    Eur Radiol. 2021 May 11. pii: 10.1007/s00330-021-07858.
    PubMed     Abstract available


  117. BAE H, Lee H, Kim S, Han K, et al
    Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists.
    Eur Radiol. 2021 May 10. pii: 10.1007/s00330-021-07877.
    PubMed     Abstract available


  118. REIMER RP, Grosse Hokamp N, Fehrmann Efferoth A, Krauskopf A, et al
    Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.
    Eur Radiol. 2021;31:3468-3477.
    PubMed     Abstract available


  119. SCHULLIAN P, Johnston E, Laimer G, Putzer D, et al
    Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Eur Radiol. 2021;31:3042-3052.
    PubMed     Abstract available


  120. SAVIC LJ, Chapiro J, Funai E, Bousabarah K, et al
    Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Eur Radiol. 2021;31:3002-3014.
    PubMed     Abstract available


    April 2021
  121. LIN CC, Lui KW, Chen WT, Hsieh YC, et al
    Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 25. pii: 10.1007/s00330-021-07729.
    PubMed     Abstract available


  122. PARK HJ, Park B, Park SY, Choi SH, et al
    Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Eur Radiol. 2021 Apr 23. pii: 10.1007/s00330-021-07926.
    PubMed     Abstract available


  123. LEE HJ, Hong SB, Lee NK, Kim S, et al
    Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07955.
    PubMed     Abstract available


  124. RYU H, Shin SY, Lee JY, Lee KM, et al
    Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07850.
    PubMed     Abstract available


  125. TANG M, Zhou Q, Huang M, Sun K, et al
    Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021 Apr 20. pii: 10.1007/s00330-021-07941.
    PubMed     Abstract available


  126. CUNHA GM, Hasenstab KA, Delgado T, Ichikawa S, et al
    Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 19. pii: 10.1007/s00330-021-07924.
    PubMed     Abstract available


  127. CHEN J, Xia C, Duan T, Cao L, et al
    Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07898.
    PubMed     Abstract available


  128. HWANG JA, Min JH, Kang TW, Jeong WK, et al
    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07897.
    PubMed     Abstract available


  129. STROBEL D, Jung EM, Ziesch M, Praktiknjo M, et al
    Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS(R)/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07872.
    PubMed     Abstract available


  130. GHORRA C, Pommier R, Piveteau A, Rubbia-Brandt L, et al
    The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Eur Radiol. 2021;31:2451-2460.
    PubMed     Abstract available


  131. DEFREYNE L
    Interventional radiology for liver diseases.
    Eur Radiol. 2021;31:2227-2230.
    PubMed    


  132. KIM DH, Choi SH, Park SH, Kim KW, et al
    The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:2497-2506.
    PubMed     Abstract available


  133. VOGL TJ, Marko C, Langenbach MC, Naguib NNN, et al
    Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
    Eur Radiol. 2021;31:2242-2251.
    PubMed     Abstract available


    March 2021
  134. YANG W, Kim JE, Choi HC, Park MJ, et al
    T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07805.
    PubMed     Abstract available


  135. ZHANG Y, Tang W, Xie S, Chen J, et al
    The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07807.
    PubMed     Abstract available


  136. TSAI YC, Shih JH, Hwang HE, Chiu NC, et al
    Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Eur Radiol. 2021 Mar 25. pii: 10.1007/s00330-021-07843.
    PubMed     Abstract available


  137. KIM DW, Lee G, Kim SY, Ahn G, et al
    Deep learning-based algorithm to detect primary hepatic malignancy in multiphase CT of patients at high risk for HCC.
    Eur Radiol. 2021 Mar 18. pii: 10.1007/s00330-021-07803.
    PubMed     Abstract available


  138. CHA DI, Lee MW, Jeong WK, Ahn SH, et al
    Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation.
    Eur Radiol. 2021 Mar 13. pii: 10.1007/s00330-021-07769.
    PubMed     Abstract available


  139. RONOT M, Ferraioli G, Muller HP, Friedrich-Rust M, et al
    Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.
    Eur Radiol. 2021;31:1578-1587.
    PubMed     Abstract available


  140. SARWAR A, Kudla A, Weinstein JL, Ali A, et al
    Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
    Eur Radiol. 2021;31:1316-1324.
    PubMed     Abstract available


  141. XU X, Zhu H, Li R, Lin H, et al
    Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.
    Eur Radiol. 2021;31:1748-1759.
    PubMed     Abstract available


  142. SHAGHAGHI M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, et al
    Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
    Eur Radiol. 2021;31:1378-1390.
    PubMed     Abstract available


  143. LEFEBVRE T, Hebert M, Bilodeau L, Sebastiani G, et al
    Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.
    Eur Radiol. 2021;31:1347-1358.
    PubMed     Abstract available


  144. COLAGRANDE S, Calistri L, Campani C, Dragoni G, et al
    CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.
    Eur Radiol. 2021;31:1608-1619.
    PubMed     Abstract available


    February 2021
  145. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2021 Feb 26. pii: 10.1007/s00330-021-07793.
    PubMed     Abstract available


  146. GOU Q, Wu L, Cui W, Mo Z, et al
    Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study.
    Eur Radiol. 2021 Feb 13. pii: 10.1007/s00330-021-07716.
    PubMed     Abstract available


  147. LIU C, Sun Y, Yang Y, Feng Y, et al
    Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
    Eur Radiol. 2021 Feb 3. pii: 10.1007/s00330-021-07702.
    PubMed     Abstract available


  148. LEE S, Kim SS, Bae H, Shin J, et al
    Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:855-863.
    PubMed     Abstract available


  149. DING J, Long L, Zhang X, Chen C, et al
    Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Eur Radiol. 2021;31:847-854.
    PubMed     Abstract available


    January 2021
  150. YANG J, Huang JY, Chen X, Ling WW, et al
    Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Jan 25. pii: 10.1007/s00330-020-07656.
    PubMed     Abstract available


  151. KENNEDY P, Lewis S, Bane O, Hectors SJ, et al
    Early effect of (90)Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience.
    Eur Radiol. 2021 Jan 21. pii: 10.1007/s00330-020-07636.
    PubMed     Abstract available


  152. BEAUMONT H, Iannessi A, Bertrand AS, Cucchi JM, et al
    Harmonization of radiomic feature distributions: impact on classification of hepatic tissue in CT imaging.
    Eur Radiol. 2021 Jan 18. pii: 10.1007/s00330-020-07641.
    PubMed     Abstract available


  153. CHONG HH, Yang L, Sheng RF, Yu YL, et al
    Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma
    Eur Radiol. 2021 Jan 14. pii: 10.1007/s00330-020-07601.
    PubMed     Abstract available


  154. HECTORS SJ, Bane O, Kennedy P, Cuevas J, et al
    Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen.
    Eur Radiol. 2021 Jan 7. pii: 10.1007/s00330-020-07495.
    PubMed     Abstract available


  155. DARNELL A, Rimola J, Belmonte E, Ripoll E, et al
    Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07457.
    PubMed     Abstract available


  156. HWANG SH, Park MS, Park S, Lim JS, et al
    Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07468.
    PubMed     Abstract available


  157. ZHOU GP, Jiang YZ, Sun LY, Zhu ZJ, et al
    Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07525.
    PubMed     Abstract available


  158. OESTMANN PM, Wang CJ, Savic LJ, Hamm CA, et al
    Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07559.
    PubMed     Abstract available


  159. ZHUANG BW, Li W, Wang W, Li B, et al
    Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07551.
    PubMed     Abstract available


  160. AN C, Li WZ, Huang ZM, Yu XL, et al
    Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    Eur Radiol. 2021 Jan 5. pii: 10.1007/s00330-020-07571.
    PubMed     Abstract available


  161. PARK SH, Shim YS, Kim B, Kim SY, et al
    Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
    Eur Radiol. 2021 Jan 3. pii: 10.1007/s00330-020-07577.
    PubMed     Abstract available


  162. ALSHEHRI E, Lam CZ, Kamath BM, Chavhan GB, et al
    Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases.
    Eur Radiol. 2021;31:292-301.
    PubMed     Abstract available


  163. GU K, Jeon TY, Yoo SY, Kim JH, et al
    Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Eur Radiol. 2021;31:283-291.
    PubMed     Abstract available


  164. SEO N, Jeong HK, Choi JY, Park MS, et al
    Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions.
    Eur Radiol. 2021;31:222-231.
    PubMed     Abstract available


  165. STEINKOHL F, Barbieri F, Senoner T, Strobl S, et al
    Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Eur Radiol. 2021;31:494-503.
    PubMed     Abstract available


  166. TSAUO J, Noh SY, Shin JH, Gwon DI, et al
    Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study.
    Eur Radiol. 2021;31:559-566.
    PubMed     Abstract available


    December 2020
  167. VOSSHENRICH J, Zech CJ, Heye T, Boldanova T, et al
    Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
    Eur Radiol. 2020 Dec 3. pii: 10.1007/s00330-020-07511.
    PubMed     Abstract available


  168. VELTRI A, Basile D, Calandri M, Bertaggia C, et al
    Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Eur Radiol. 2020;30:6958-6964.
    PubMed     Abstract available


    November 2020
  169. PACHEV A, Raynaud L, Paulatto L, Burgio MD, et al
    Correction to: Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07506.
    PubMed     Abstract available


  170. ZHANG J, Wu Z, Zhao J, Liu S, et al
    Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07524.
    PubMed     Abstract available


  171. CHU HH, Chun SY, Kim JH, Kim PH, et al
    A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava.
    Eur Radiol. 2020 Nov 26. pii: 10.1007/s00330-020-07536.
    PubMed     Abstract available


  172. SEO N, Kim MS, Park MS, Choi JY, et al
    Correction to: Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Eur Radiol. 2020 Nov 23. pii: 10.1007/s00330-020-07444.
    PubMed     Abstract available


  173. BAE JS, Kim JH, Lee DH, Kim JH, et al
    Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
    Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07499.
    PubMed     Abstract available


  174. HU X, Huang X, Hou J, Ding L, et al
    Correction to: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Nov 18. pii: 10.1007/s00330-020-07446.
    PubMed     Abstract available


  175. YANG Y, Chen Y, Ye F, Cao X, et al
    Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Eur Radiol. 2020 Nov 11. pii: 10.1007/s00330-020-07460.
    PubMed     Abstract available


  176. MIN JH, Kang TW, Kim YY, Cha DI, et al
    Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
    Eur Radiol. 2020 Nov 7. pii: 10.1007/s00330-020-07438.
    PubMed     Abstract available


  177. KIM SS, Lee S, Kim MJ
    Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07419.
    PubMed     Abstract available


  178. REIZINE E, Ronot M, Ghosn M, Calderaro J, et al
    Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked beta-catenin activation in hepatocellular adenoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07434.
    PubMed     Abstract available


  179. LI C, Ye J, Prince M, Peng Y, et al
    Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model.
    Eur Radiol. 2020;30:6022-6032.
    PubMed     Abstract available


  180. KROMREY ML, Tamada D, Johno H, Funayama S, et al
    Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network.
    Eur Radiol. 2020;30:5923-5932.
    PubMed     Abstract available


  181. PLAIKNER M, Kremser C, Zoller H, Jaschke W, et al
    Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences.
    Eur Radiol. 2020;30:5826-5833.
    PubMed     Abstract available


  182. QIAO W, Yu Y, Huang Y, Gao W, et al
    Impact of focused ultrasound on the ethanol ablation of VX2 liver tumours in rabbits.
    Eur Radiol. 2020;30:5862-5870.
    PubMed     Abstract available


    October 2020
  183. LADA NE, Gupta A, Anderson SW, Dinh DC, et al
    Liver trauma: hepatic vascular injury on computed tomography as a predictor of patient outcome.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07373.
    PubMed     Abstract available


  184. DOEMEL LA, Chapiro J, Laage Gaupp F, Savic LJ, et al
    Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07381.
    PubMed     Abstract available


  185. CHUANG YH, Hsieh CS, Lai MW, Chen CC, et al
    Detection of pediatric hepatic steatosis through ultrasound backscattering analysis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07391.
    PubMed     Abstract available


  186. LEE CM, Lee SS, Choi WM, Kim KM, et al
    An index based on deep learning-measured spleen volume on CT for the assessment of high-risk varix in B-viral compensated cirrhosis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07430.
    PubMed     Abstract available


  187. PACHEV A, Rauyaud L, Paulatto L, Dioguardi Burgio M, et al
    Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 29. pii: 10.1007/s00330-020-07404.
    PubMed     Abstract available


  188. HWANG SH, Hong SB, Park S, Han K, et al
    Subcentimeter hepatocellular carcinoma in treatment-naive patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07329.
    PubMed     Abstract available


  189. CHOUHAN MD, Taylor SA, Bainbridge A, Walker-Samuel S, et al
    Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07259.
    PubMed     Abstract available


  190. LUO N, Li W, Xie J, Fu D, et al
    Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.
    Eur Radiol. 2020 Oct 9. pii: 10.1007/s00330-020-07330.
    PubMed     Abstract available


  191. CHU H, Liu Z, Liang W, Zhou Q, et al
    Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07250.
    PubMed     Abstract available


  192. KIM B, Kim SS, Cho SW, Cheong JY, et al
    Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07357.
    PubMed     Abstract available


  193. BAE JS, Lee DH, Yoo J, Yi NJ, et al
    Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07313.
    PubMed     Abstract available


  194. LI J, Sehrawat TS, Chen J, Hilscher MB, et al
    Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07341.
    PubMed     Abstract available


  195. WEI H, Jiang H, Zheng T, Zhang Z, et al
    LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Eur Radiol. 2020 Oct 1. pii: 10.1007/s00330-020-07303.
    PubMed     Abstract available


  196. ZHANG L, Yu X, Wei W, Pan X, et al
    Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
    Eur Radiol. 2020;30:5327-5336.
    PubMed     Abstract available


    September 2020
  197. BONATTI M, Valletta R, Avesani G, Lombardo F, et al
    Liver enhancement during hepatobiliary phase after Gd-BOPTA administration: correlation with liver and renal function.
    Eur Radiol. 2020 Sep 30. pii: 10.1007/s00330-020-07279.
    PubMed     Abstract available


  198. HU X, Huang X, Hou J, Ding L, et al
    Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Sep 24. pii: 10.1007/s00330-020-07223.
    PubMed     Abstract available


  199. RUNGE JH, van Giessen J, Draijer LG, Deurloo EE, et al
    Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07245.
    PubMed     Abstract available


  200. ALIYARI GHASABEH M, Shaghaghi M, Pandey A, Ameli S, et al
    Integrating baseline MR imaging biomarkers into BCLC and CLIP improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07251.
    PubMed     Abstract available


  201. KIM SS, Lee S, Bae H, Chung YE, et al
    Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07229.
    PubMed     Abstract available


  202. BHAYANA R, Baliyan V, Kordbacheh H, Kambadakone A, et al
    Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07228.
    PubMed     Abstract available


  203. LEE JH, Yoon CJ, Choi WS
    Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure.
    Eur Radiol. 2020 Sep 3. pii: 10.1007/s00330-020-07139.
    PubMed     Abstract available


  204. KALARAKIS G, Perisinakis K, Akoumianakis E, Karageorgiou I, et al
    CT liver perfusion in patients with hepatocellular carcinoma: can we modify acquisition protocol to reduce patient exposure?
    Eur Radiol. 2020 Sep 2. pii: 10.1007/s00330-020-07206.
    PubMed     Abstract available


  205. NOUGARET S, Monsonis B, Molinari N, Riviere B, et al
    Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
    Eur Radiol. 2020;30:4752-4761.
    PubMed     Abstract available


  206. IDILMAN IS, Venkatesh SH, Eaton JE, Bolan CW, et al
    Magnetic resonance imaging features in 283 patients with primary biliary cholangitis.
    Eur Radiol. 2020;30:5139-5148.
    PubMed     Abstract available


    August 2020
  207. KANG HJ, Lee JM, Jeon SK, Jang S, et al
    Intra-individual comparison of dual portal venous phases for non-invasive diagnosis of hepatocellular carcinoma at gadoxetic acid-enhanced liver MRI.
    Eur Radiol. 2020 Aug 26. pii: 10.1007/s00330-020-07162.
    PubMed     Abstract available


  208. NODA Y, Tochigi T, Baliyan V, Kordbacheh H, et al
    Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
    Eur Radiol. 2020 Aug 12. pii: 10.1007/s00330-020-07115.
    PubMed     Abstract available


  209. CATANIA R, Furlan A, Smith AD, Behari J, et al
    Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
    Eur Radiol. 2020 Aug 5. pii: 10.1007/s00330-020-07114.
    PubMed     Abstract available


  210. LIU X, Khalvati F, Namdar K, Fischer S, et al
    Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07119.
    PubMed     Abstract available


  211. MESROPYAN N, Isaak A, Faron A, Praktiknjo M, et al
    Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension.
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07080.
    PubMed     Abstract available


  212. VIETTI VIOLI N, Taouli B
    Abbreviated MRI for HCC surveillance: is it ready for clinical use?
    Eur Radiol. 2020;30:4147-4149.
    PubMed     Abstract available


  213. SCHAWKAT K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, et al
    Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology.
    Eur Radiol. 2020;30:4675-4685.
    PubMed     Abstract available


  214. CHO HJ, Kim B, Kim HJ, Huh J, et al
    Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Eur Radiol. 2020;30:4182-4192.
    PubMed     Abstract available


    July 2020
  215. ZHANG Y, Miao H, Xie W, Jiang S, et al
    The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Eur Radiol. 2020 Jul 29. pii: 10.1007/s00330-020-07078.
    PubMed     Abstract available


  216. MAO B, Zhang L, Ning P, Ding F, et al
    Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Eur Radiol. 2020 Jul 22. pii: 10.1007/s00330-020-07056.
    PubMed     Abstract available


  217. AMELI S, Shaghaghi M, Ghasabeh MA, Pandey P, et al
    Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma?
    Eur Radiol. 2020 Jul 15. pii: 10.1007/s00330-020-07052.
    PubMed     Abstract available


  218. CHA DI, Choi GS, Kim YK, Kim JM, et al
    Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
    Eur Radiol. 2020;30:3723-3734.
    PubMed     Abstract available


  219. VOGL TJ, Martin SS, Johnson AA, Haas Y, et al
    Evaluation of MR elastography as a response parameter for transarterial chemoembolization of colorectal liver metastases.
    Eur Radiol. 2020;30:3900-3907.
    PubMed     Abstract available


    June 2020
  220. HAYOZ R, Vietti-Violi N, Duran R, Knebel JF, et al
    The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Eur Radiol. 2020 Jun 29. pii: 10.1007/s00330-020-06930.
    PubMed     Abstract available


  221. KERAMIDA G, Gregg S, Peters AM
    Stimulation of the hepatic arterial buffer response using exogenous adenosine: hepatic rest/stress perfusion imaging.
    Eur Radiol. 2020 Jun 27. pii: 10.1007/s00330-020-06984.
    PubMed     Abstract available


  222. VIETTI VIOLI N, Lewis S, Liao J, Hulkower M, et al
    Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Eur Radiol. 2020 Jun 25. pii: 10.1007/s00330-020-07014.
    PubMed     Abstract available


  223. FENG Y, Wu H, Huang DQ, Xu C, et al
    Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (
    Eur Radiol. 2020 Jun 11. pii: 10.1007/s00330-020-06990.
    PubMed     Abstract available


  224. ICHIKAWA S, Isoda H, Shimizu T, Tamada D, et al
    Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Eur Radiol. 2020 Jun 4. pii: 10.1007/s00330-020-06972.
    PubMed     Abstract available


  225. SON JH, Lee SS, Lee Y, Kang BK, et al
    Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.
    Eur Radiol. 2020;30:3486-3496.
    PubMed     Abstract available


    May 2020
  226. DORI Y, Smith CL, DeWitt AG, Srinivasan A, et al
    Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography.
    Eur Radiol. 2020 May 27. pii: 10.1007/s00330-020-06949.
    PubMed     Abstract available


  227. SCHOBERT IT, Savic LJ, Chapiro J, Bousabarah K, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Eur Radiol. 2020 May 19. pii: 10.1007/s00330-020-06931.
    PubMed     Abstract available


  228. KIM PH, Gwon DI, Kim JW, Chu HH, et al
    The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Eur Radiol. 2020 May 15. pii: 10.1007/s00330-020-06911.
    PubMed     Abstract available


  229. MULE S, Chalaye J, Legou F, Tenenhaus A, et al
    Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Eur Radiol. 2020 May 13. pii: 10.1007/s00330-020-06923.
    PubMed     Abstract available


  230. WANG X, Wang W, Ma X, Lu X, et al
    Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Eur Radiol. 2020 May 8. pii: 10.1007/s00330-020-06861.
    PubMed     Abstract available


  231. LYU L, Liu XL, Rui MP, Yang LC, et al
    Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis.
    Eur Radiol. 2020 May 6. pii: 10.1007/s00330-020-06902.
    PubMed     Abstract available


  232. CHEN J, Zhu J, Zhang C, Song Y, et al
    Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
    Eur Radiol. 2020;30:2871-2880.
    PubMed     Abstract available


  233. STOCKER D, Becker AS, Barth BK, Skawran S, et al
    Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?
    Eur Radiol. 2020;30:2922-2933.
    PubMed     Abstract available


  234. KIM SW, Joo I, Kim HC, Ahn SJ, et al
    LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.
    Eur Radiol. 2020;30:2861-2870.
    PubMed     Abstract available


    April 2020
  235. GREGORY J, Crequit P, Vilgrain V, Ronot M, et al
    Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported.
    Eur Radiol. 2020 Apr 30. pii: 10.1007/s00330-020-06900.
    PubMed     Abstract available


  236. BAK S, Kim JE, Bae K, Cho JM, et al
    Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis.
    Eur Radiol. 2020 Apr 26. pii: 10.1007/s00330-020-06876.
    PubMed     Abstract available


  237. JEON SK, Lee JM, Joo I, Yoo J, et al
    Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
    Eur Radiol. 2020 Apr 25. pii: 10.1007/s00330-020-06881.
    PubMed     Abstract available


  238. MAMIDIPALLI A, Fowler KJ, Hamilton G, Wolfson T, et al
    Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06858.
    PubMed     Abstract available


  239. DUAN Y, Xie X, Li Q, Mercaldo N, et al
    Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Eur Radiol. 2020 Apr 19. pii: 10.1007/s00330-020-06834.
    PubMed     Abstract available


  240. PARK SH, Kim B, Kim SY, Shim YS, et al
    Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort.
    Eur Radiol. 2020;30:2302-2311.
    PubMed     Abstract available


    March 2020
  241. LUEDEMANN WM, Geisel D, Gebauer B, Schnapauff D, et al
    Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?
    Eur Radiol. 2020;30:1601-1608.
    PubMed     Abstract available


  242. REZVANI HABIBABADI R, Khoshpouri P, Ghadimi M, Shaghaghi M, et al
    Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography.
    Eur Radiol. 2020;30:1609-1615.
    PubMed     Abstract available


  243. WITOWSKI J, Budzynski A, Grochowska A, Ballard DH, et al
    Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study.
    Eur Radiol. 2020;30:1306-1312.
    PubMed     Abstract available


  244. REINERT CP, Sekler J, la Fougere C, Pfannenberg C, et al
    Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
    Eur Radiol. 2020;30:1325-1333.
    PubMed     Abstract available


    February 2020
  245. CHEN J, Wu Z, Xia C, Jiang H, et al
    Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020;30:1232-1242.
    PubMed     Abstract available


  246. CAZZATO RL, De Marini P, Leclerc L, Dalili D, et al
    Large nearly spherical ablation zones are achieved with simultaneous multi-antenna microwave ablation applied to treat liver tumours.
    Eur Radiol. 2020;30:971-975.
    PubMed     Abstract available


  247. LEE JH, Joo I, Kang TW, Paik YH, et al
    Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.
    Eur Radiol. 2020;30:1264-1273.
    PubMed     Abstract available


  248. LEE S, Kim KW, Jeong WK, Kim MJ, et al
    Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Eur Radiol. 2020;30:987-995.
    PubMed     Abstract available


  249. CASSINOTTO C, Pierredon-Foulongne MA, Belgour A, Delicque J, et al
    Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound.
    Eur Radiol. 2020;30:1088-1095.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: